General Announcement::NDA for Additional Indication AD for Ruxolitinib Cream Accepted and Granted Priority Review in China

Issuer & Securities

Issuer/ Manager
CHINA MEDICAL SYSTEM HOLDINGS LIMITED
Securities
CHINA MEDICAL SYSTEM HLDGS LTD - KYG211081248 - 8A8
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
24-Feb-2026 17:53:45
Status
New
Announcement Sub Title
NDA for Additional Indication AD for Ruxolitinib Cream Accepted and Granted Priority Review in China
Announcement Reference
SG260224OTHRUX43
Submitted By (Co./ Ind. Name)
Wu Sanyan
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Please refer to the attachment.

Attachments

CMS-NDA for Additional Indication AD for Ruxolitinib Cream Accepted and Granted Priority Review in China.pdf
Total size =169K